Tumor Microenvironment-Responsive Polymer Delivery Platforms for Cancer Therapy.

Area of Science:

• Biomaterials Science
• Nanotechnology
• Oncology

Background:

• Chemotherapeutic and bioimaging agents often suffer from poor bioavailability, limited biocompatibility, and lack of specific targeting.
• This leads to reduced anticancer efficacy and inaccurate diagnostic imaging, posing significant challenges in cancer treatment.

Purpose of the Study:

• To review recent advancements in stimuli-responsive polymer delivery platforms that utilize the tumor microenvironment (TME).
• To analyze the molecular design and responsive mechanisms of these platforms.
• To summarize their applications in drug delivery and diagnostic imaging for cancer.

Main Methods:

• Comprehensive literature review of TME-responsive polymer delivery systems.
• Analysis of platforms responding to pH, reactive oxygen species (ROS), glutathione (GSH), enzymes, and hypoxia.
• Examination of molecular design, responsive mechanisms, and bio-applications.

Main Results:

• TME-responsive polymer platforms offer controlled release of therapeutic and diagnostic agents at the tumor site.
• These systems improve targeting specificity, enhancing anticancer treatment efficacy and imaging precision.
• They also minimize damage to healthy tissues and reduce false imaging signals from non-specific drug leakage.

Conclusions:

• TME-responsive polymer delivery platforms represent a promising strategy to overcome limitations of conventional cancer therapies and diagnostics.
• Further research into molecular and vector design is crucial for optimizing their performance.
• These platforms hold significant potential for future advancements in precision oncology.